Cepheid's Xpert GBS(TM) Test for Group B Streptococcus Run on the GeneXpert(R) System Receives 510(k) Clearance From FDA (PR Newswire via Yahoo! Finance)
Cepheid , a broad-based molecular diagnostics company, today announced the 510 clearance of its first clinical molecular diagnostic product for the Unites States market.

SHIRE PLC: Second quarter 2006 results (FinanzNachrichten)
First 2006 product launched, another approved and pipeline progression on track Basingstoke, UK and Philadelphia, US - July 28, 2006 - Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announces results for the second quarter 2006 and confirms good progression in drugs pipeline.